BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7945177)

  • 1. Extracellular matrix degrading metalloproteinases in the pathogenesis of arteriosclerosis.
    Newby AC; Southgate KM; Davies M
    Basic Res Cardiol; 1994; 89 Suppl 1():59-70. PubMed ID: 7945177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation.
    Southgate KM; Davies M; Booth RF; Newby AC
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):93-9. PubMed ID: 1445285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.
    Galis ZS; Sukhova GK; Lark MW; Libby P
    J Clin Invest; 1994 Dec; 94(6):2493-503. PubMed ID: 7989608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases. Their role in degenerative chronic diseases of abdominal aorta.
    Palombo D; Maione M; Cifiello BI; Udini M; Maggio D; Lupo M
    J Cardiovasc Surg (Torino); 1999 Apr; 40(2):257-60. PubMed ID: 10350113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradation.
    Reynolds JJ
    Oral Dis; 1996 Mar; 2(1):70-6. PubMed ID: 8957940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunolocalization of matrix metalloproteinases in rabbit carotid arteries after balloon denudation.
    Aoyagi M; Yamamoto M; Azuma H; Nagashima G; Niimi Y; Tamaki M; Hirakawa K; Yamamoto K
    Histochem Cell Biol; 1998 Feb; 109(2):97-102. PubMed ID: 9504769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent regulation by growth factors and cytokines of 95 kDa and 72 kDa gelatinases and tissue inhibitors or metalloproteinases-1, -2, and -3 in rabbit aortic smooth muscle cells.
    Fabunmi RP; Baker AH; Murray EJ; Booth RF; Newby AC
    Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):335-42. PubMed ID: 8670128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture?
    Schönbeck U; Mach F; Sukhova GK; Murphy C; Bonnefoy JY; Fabunmi RP; Libby P
    Circ Res; 1997 Sep; 81(3):448-54. PubMed ID: 9285647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased secretion of gelatinases A and B from the aortas of cholesterol fed rabbits: relationship to lesion severity.
    Zaltsman AB; Newby AC
    Atherosclerosis; 1997 Apr; 130(1-2):61-70. PubMed ID: 9126649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases.
    Galis ZS; Sukhova GK; Kranzhöfer R; Clark S; Libby P
    Proc Natl Acad Sci U S A; 1995 Jan; 92(2):402-6. PubMed ID: 7831299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy?
    Galis ZS; Asanuma K; Godin D; Meng X
    Circulation; 1998 Jun; 97(24):2445-53. PubMed ID: 9641697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases degrade insulin-like growth factor-binding protein-3 in dermal fibroblast cultures.
    Fowlkes JL; Enghild JJ; Suzuki K; Nagase H
    J Biol Chem; 1994 Oct; 269(41):25742-6. PubMed ID: 7523391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions.
    Galis ZS; Muszynski M; Sukhova GK; Simon-Morrissey E; Libby P
    Ann N Y Acad Sci; 1995 Jan; 748():501-7. PubMed ID: 7695193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chondrocyte cultures express matrix metalloproteinase mRNA and immunoreactive protein; stromelysin-1 and 72 kDa gelatinase are localized in extracellular matrix vesicles.
    Schmitz JP; Dean DD; Schwartz Z; Cochran DL; Grant GM; Klebe RJ; Nakaya H; Boyan BD
    J Cell Biochem; 1996 Jun; 61(3):375-91. PubMed ID: 8761942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human vascular smooth muscle cell-monocyte interactions and metalloproteinase secretion in culture.
    Lee E; Grodzinsky AJ; Libby P; Clinton SK; Lark MW; Lee RT
    Arterioscler Thromb Vasc Biol; 1995 Dec; 15(12):2284-9. PubMed ID: 7489254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stromal cell expression of components of matrix-degrading protease systems in human cancer.
    Hewitt R; Danø K
    Enzyme Protein; 1996; 49(1-3):163-73. PubMed ID: 8797004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion.
    Galis ZS; Muszynski M; Sukhova GK; Simon-Morrissey E; Unemori EN; Lark MW; Amento E; Libby P
    Circ Res; 1994 Jul; 75(1):181-9. PubMed ID: 8013077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased matrix metalloproteinases in the aqueous humor of patients and experimental animals with uveitis.
    Di Girolamo N; Verma MJ; McCluskey PJ; Lloyd A; Wakefield D
    Curr Eye Res; 1996 Oct; 15(10):1060-8. PubMed ID: 8921246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases and their inhibitors in tumour growth and invasion.
    Kähäri VM; Saarialho-Kere U
    Ann Med; 1999 Feb; 31(1):34-45. PubMed ID: 10219712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinase by myofibroblasts--morphological study on corneal wound healing].
    Shimoda M; Ishizaki M; Saiga T; Yamanaka N
    Nippon Ganka Gakkai Zasshi; 1997 May; 101(5):371-9. PubMed ID: 9170840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.